A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).
Saved in:
| Title: | A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). |
|---|---|
| Authors: | Chen, Hua-Jun1 (AUTHOR), Tu, Hai-Yan1 (AUTHOR), Hu, Yanping2 (AUTHOR), Fan, Yun3 (AUTHOR), Wu, Guowu4 (AUTHOR), Cang, Shundong5 (AUTHOR), Yang, Yi6 (AUTHOR), Yang, Nong7 (AUTHOR), Ma, Rui8 (AUTHOR), Jin, Gaowa9 (AUTHOR), Xu, Ximing10 (AUTHOR), Liu, Anwen11 (AUTHOR), Tang, Shubin12 (AUTHOR), Cheng, Ying13 (AUTHOR), Yu, Yan14 (AUTHOR), Xu, Chong-Rui1 (AUTHOR), Zhou, Qing1 (AUTHOR), Wu, Yi-Long1 (AUTHOR) syylwu@live.cn |
| Source: | Journal of Hematology & Oncology. 1/5/2025, Vol. 18 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 182098089 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chen%2C+Hua-Jun%22">Chen, Hua-Jun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tu%2C+Hai-Yan%22">Tu, Hai-Yan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Yanping%22">Hu, Yanping</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fan%2C+Yun%22">Fan, Yun</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Guowu%22">Wu, Guowu</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cang%2C+Shundong%22">Cang, Shundong</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Yi%22">Yang, Yi</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Nong%22">Yang, Nong</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Rui%22">Ma, Rui</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jin%2C+Gaowa%22">Jin, Gaowa</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Ximing%22">Xu, Ximing</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Anwen%22">Liu, Anwen</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Shubin%22">Tang, Shubin</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Ying%22">Cheng, Ying</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Yan%22">Yu, Yan</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Chong-Rui%22">Xu, Chong-Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Qing%22">Zhou, Qing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Yi-Long%22">Wu, Yi-Long</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> syylwu@live.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Hematology+%26+Oncology%22">Journal of Hematology & Oncology</searchLink>. 1/5/2025, Vol. 18 Issue 1, p1-10. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=182098089 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13045-024-01656-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Titles: – TitleFull: A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen, Hua-Jun – PersonEntity: Name: NameFull: Tu, Hai-Yan – PersonEntity: Name: NameFull: Hu, Yanping – PersonEntity: Name: NameFull: Fan, Yun – PersonEntity: Name: NameFull: Wu, Guowu – PersonEntity: Name: NameFull: Cang, Shundong – PersonEntity: Name: NameFull: Yang, Yi – PersonEntity: Name: NameFull: Yang, Nong – PersonEntity: Name: NameFull: Ma, Rui – PersonEntity: Name: NameFull: Jin, Gaowa – PersonEntity: Name: NameFull: Xu, Ximing – PersonEntity: Name: NameFull: Liu, Anwen – PersonEntity: Name: NameFull: Tang, Shubin – PersonEntity: Name: NameFull: Cheng, Ying – PersonEntity: Name: NameFull: Yu, Yan – PersonEntity: Name: NameFull: Xu, Chong-Rui – PersonEntity: Name: NameFull: Zhou, Qing – PersonEntity: Name: NameFull: Wu, Yi-Long IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 01 Text: 1/5/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 17568722 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Journal of Hematology & Oncology Type: main |
| ResultId | 1 |